A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated

NCT06745297 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 3776528
DRUG: Placebo matching BI 3776528
DRUG: short-acting benzodiazepine

Sponsor

Boehringer Ingelheim